Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug;42(8):1994-2001.
doi: 10.1002/hed.26135. Epub 2020 Mar 1.

Positive lymph node number and extranodal extension for predicting recurrence and survival in patients with salivary gland cancer

Affiliations

Positive lymph node number and extranodal extension for predicting recurrence and survival in patients with salivary gland cancer

Hojun Lee et al. Head Neck. 2020 Aug.

Abstract

Background: This study compared our proposed N classification including the addition of the number of positive lymph node (LN+) and extranodal extension (ENE) with the current and previous American Joint Committee on Cancer (AJCC) N classifications in salivary gland cancer (SGC).

Methods: This study involved 172 SGC patients who underwent surgery. Cox proportional hazard regression analyses were used to identify factors associated with overall survival (OS) and disease-free survival (DFS).

Results: In multivariate analyses, LN+ number, LN ratio, and ENE were associated with OS and DFS outcomes (all P < .05). Our new N classification proposed three categories: N0 (0 LN+), N1 (1 LN+), and N2 (≥2 LN+ or ENE). The C-index of our N classification showed improvement in OS prediction (0.768) compared with the AJCC seventh (0.743) and eighth (0.756) edition N classifications.

Conclusions: Our proposed N classification incorporating LN+ number and ENE may improve prediction of post-treatment survival and recurrence in patients with SGC.

Keywords: N classification; extranodal extension; lymph node metastasis; prognosis; salivary gland cancer.

PubMed Disclaimer

References

REFERENCES

    1. Speight PM, Barrett AW. Salivary gland tumours. Oral Dis. 2002;8(5):229-240.
    1. Pinkston JA, Cole P. Incidence rates of salivary gland tumors: results from a population-based study. Otolaryngol Head Neck Surg. 1999;120(6):834-840.
    1. Suh JD, Cho JH. Trends in head and neck cancer in South Korea between 1999 and 2012. Clin Exp Otorhinolaryngol. 2016;9(3):263-269.
    1. Fu JY, Wu CX, Shen SK, Zheng Y, Zhang CP, Zhang ZY. Salivary gland carcinoma in Shanghai (2003-2012): an epidemiological study of incidence, site and pathology. BMC Cancer. 2019;19(1):350.
    1. Bjorndal K, Krogdahl A, Therkildsen MH, et al. Salivary gland carcinoma in Denmark 1990-2005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA). Oral Oncol. 2011;47(7):677-682.

Publication types

LinkOut - more resources